Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Photolithographic patterning of C2C12 myotubes using vitronectin as growth substrate in serum-free medium.

Tytuł:
Photolithographic patterning of C2C12 myotubes using vitronectin as growth substrate in serum-free medium.
Autorzy:
Molnar P; Nanoscience Technology Center, University of Central Florida, 12424 Research Parkway, Suite 400, Orlando, Florida 32826, USA. />Wang W
Natarajan A
Rumsey JW
Hickman JJ
Źródło:
Biotechnology progress [Biotechnol Prog] 2007 Jan-Feb; Vol. 23 (1), pp. 265-8.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
Język:
English
Imprint Name(s):
Publication: <2010-> : Hoboken, NJ : Wiley-Blackwell
Original Publication: [New York, N.Y. : American Institute of Chemical Engineers, c1985-
MeSH Terms:
Cell Culture Techniques/*methods
Muscle Cells/*cytology
Muscle Fibers, Skeletal/*cytology
Tissue Engineering/*methods
Vitronectin/*administration & dosage
Animals ; Cell Differentiation/drug effects ; Cell Line ; Coated Materials, Biocompatible/administration & dosage ; Coated Materials, Biocompatible/chemistry ; Culture Media, Serum-Free ; Mice ; Muscle Cells/drug effects ; Muscle Fibers, Skeletal/drug effects ; Photography/methods ; Surface Properties ; Vitronectin/chemistry
References:
Dev Dyn. 1994 Feb;199(2):116-28. (PMID: 7515725)
Clin Plast Surg. 1999 Oct;26(4):647-56, ix-x. (PMID: 10553219)
Biomaterials. 2004 Jun;25(14):2721-30. (PMID: 14962551)
J Anim Sci. 2000 Mar;78(3):699-708. (PMID: 10764078)
J Neurosci Methods. 1998 Aug 1;82(2):167-73. (PMID: 9700689)
Biomaterials. 1999 Dec;20(23-24):2363-76. (PMID: 10614942)
Biomaterials. 2006 Jul;27(19):3580-8. (PMID: 16516288)
J Neurosci Res. 1991 Oct;30(2):300-7. (PMID: 1798054)
J Cell Sci. 1998 Sep;111 ( Pt 18):2729-40. (PMID: 9718366)
FEBS Lett. 2005 Apr 25;579(11):2469-74. (PMID: 15848190)
J Cell Biol. 2004 Sep 13;166(6):877-87. (PMID: 15364962)
Cells Tissues Organs. 2000;167(2-3):130-7. (PMID: 10971037)
Appl Microbiol Biotechnol. 2001 May;55(5):556-62. (PMID: 11414320)
Biomaterials. 2005 May;26(15):2549-57. (PMID: 15585257)
Anal Biochem. 1999 Aug 1;272(2):135-42. (PMID: 10415081)
Am J Physiol Cell Physiol. 2002 Nov;283(5):C1557-65. (PMID: 12372817)
J Nanosci Nanotechnol. 2005 Nov;5(11):1809-15. (PMID: 16433414)
J Neuroeng Rehabil. 2004 Oct 28;1(1):6. (PMID: 15679914)
J Biomed Mater Res. 2001 Oct;57(1):15-24. (PMID: 11416844)
Tissue Eng. 2001 Oct;7(5):573-84. (PMID: 11694191)
In Vitro Cell Dev Biol Anim. 1996 Feb;32(2):90-9. (PMID: 8907122)
Biotechnol Prog. 2003 Nov-Dec;19(6):1756-61. (PMID: 14656152)
J Cell Biol. 1996 Feb;132(4):657-66. (PMID: 8647896)
Exp Cell Res. 2005 Dec 10;311(2):307-16. (PMID: 16263111)
J Cell Mol Med. 2004 Oct-Dec;8(4):413-22. (PMID: 15601570)
J Neurosci Methods. 2004 Jul 30;136(2):151-63. (PMID: 15183267)
Biomaterials. 2005 May;26(13):1497-505. (PMID: 15522751)
J Biomed Mater Res. 2002 Jun 5;60(3):472-9. (PMID: 11920672)
Biochem Biophys Res Commun. 2003 Aug 8;307(4):883-90. (PMID: 12878194)
Biomaterials. 2005 Aug;26(22):4606-15. (PMID: 15722130)
Lab Chip. 2005 Jan;5(1):102-7. (PMID: 15616747)
J Cell Physiol. 2001 Jan;186(1):82-94. (PMID: 11147817)
In Vitro Cell Dev Biol Anim. 2000 May;36(5):327-35. (PMID: 10937836)
J Biomed Mater Res. 1999 Mar 15;44(4):355-70. (PMID: 10397939)
Clin Orthop Relat Res. 2002 Oct;(403 Suppl):S228-42. (PMID: 12394473)
Grant Information:
K01 EB003465 United States EB NIBIB NIH HHS; K01 EB003465-06 United States EB NIBIB NIH HHS; K01 EB003465-03 United States EB NIBIB NIH HHS
Substance Nomenclature:
0 (Coated Materials, Biocompatible)
0 (Culture Media, Serum-Free)
0 (Vitronectin)
Entry Date(s):
Date Created: 20070203 Date Completed: 20080610 Latest Revision: 20181113
Update Code:
20240104
PubMed Central ID:
PMC2566825
DOI:
10.1021/bp060302q
PMID:
17269697
Czasopismo naukowe
The C2C12 cell line is frequently used as a model of skeletal muscle differentiation. In our serum-free defined culture system, differentiation of C2C12 cells into myotubes required surface-bound signals such as substrate-adsorbed vitronectin or laminin. On the basis of this substrate requirement of myotube formation, we developed a photolithography-based method to pattern C2C12 myotubes, where myotubes formed exclusively on vitronectin surface patterns. We have determined that the optimal line width to form single myotubes is approximately 30 mum. To illustrate a possible application of this method, we patterned myotubes on the top of commercial substrate-embedded microelectrodes. In contrast to previous experiments where cell patterning was achieved by selective attachment of the cells to patterned surfaces in a medium that contained all of the factors necessary for differentiation, this study illustrates that surface patterning of a signaling molecule, which is essential for skeletal muscle differentiation in a defined system, can result in the formation of aligned myotubes on the patterns. This technique is being developed for applications in cell biology, tissue engineering, and robotics.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies